DOI QR코드

DOI QR Code

Antihyperglycemic and lipid lowering effect of Tectona grandis in alloxan induced diabetic rats

  • Ghaisas, M.M. (Principal, India College of Pharmacy) ;
  • Navghare, V.V. (Department of Pharmacology Padm. Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research) ;
  • Takawale, A.R. (Department of Pharmacology Padm. Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research) ;
  • Zope, V.S. (Department of Pharmacology Padm. Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research) ;
  • Tanwar, M.B. (Department of Pharmacology Padm. Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research) ;
  • Phanse, M.A. (Department of Pharmacology Padm. Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research)
  • Received : 2008.01.06
  • Accepted : 2010.05.06
  • Published : 2010.06.30

Abstract

In India, Tectona grandis is traditionally used in the treatment of diabetes mellitus and lipid disorder. In the present study, the antihyperglycemic and lipid lowering effect of ethanolic extract of bark of Tectona grandis (TG) was evaluated using alloxan induced diabetes in rats. Alloxan was given at the dose of 140 mg/kg, i.p. After induction of diabetes, TG was administered for 42 days p. o. and simultaneously different biochemical parameters like plasma glucose, liver glycogen content, serum triglyceride, cholesterol, LDL-cholesterol and HDL-cholesterol were estimated. Diabetic control showed significant increase (P < 0.01) in plasma glucose, serum triglyceride, cholesterol, LDL-cholesterol and significant decrease (P < 0.01) in serum HDL-cholesterol and liver glycogen content. Treatment with TG showed significant reduction (P < 0.01) in plasma glucose when compared with diabetic control. The elevated levels of serum triglyceride and cholesterol levels were significantly reduced (P < 0.01) by TG. TG treatment for 42 days showed significant decrease in serum LDL-cholesterol (P < 0.01) and significant increase in serum HDL-cholesterol level (P < 0.01). Moreover, diabetic control there was significant decrease in liver glycogen content which was significantly increased (P < 0.05) by treatment with TG. Hence, from the result obtained in the present study it can be concluded that Tectona grandis has the potential to treat diabetes condition and associated lipid disorder.

Keywords

References

  1. Carroll NV, Longley RW, Roe JH. (1955) The determination of Glycogen in liver and muscle by use of Anthrone reagent. J. Biol. Chem. 583-593.
  2. Ghaisas M, Navghare V, Takawale A, Zope V, Tanwar M, Deshpande A. (2009) Effect of Tectona grandis Linn. on dexamethasone-induced insulin resistancein mice. J. Ethnopharmacol. 122, 304-307. https://doi.org/10.1016/j.jep.2009.01.008
  3. Ghosh S, Suryawanshi SA. (2001) Effect of Vinca rosea extract in treatment of Alloxan diabetes in male albino rats. Indian J. Expt. Biol. 39, 748-759.
  4. Goyal RK, Mehta AA, Mahajan SG. (2008) Classification of Herbal Antidiabetic Based on Mechanism of Action and Chemical Constituetns. In: Govil JN, Singh VR, Mishara SK. Recent progress in medicinal plants vol 20, hytopharmacology and Therapeutic values II. USA, Stadium Press LLC, pp. 65-110.
  5. Guy K, Jaekyung K, Klaus H, Yanyan C, Xiaozhuo C. (2007) Antidiabetes and antiobesity activity of Laserstroemia speciosa. eCAM 10, 1-7.
  6. Khan RM, Miungwana SM. (1999) 5-Hydroxylapachol: a cytotoxic agent from Tectona grandis. Phytochemistry 50, 439-442. https://doi.org/10.1016/S0031-9422(98)00478-6
  7. Khandelwal KR. (2005). Practical Pharmacognosy, XIV ed. pp. 149-153 Nirali Prakashan, Pune.
  8. Khare CP. (2007) Indian Medicinal Plants. An Illustrated Dictionary, pp. 649-650, Berlin/Heidelberg. Springer-Verlag.
  9. Maiti R, Jana D, Das UK, Ghosh D. (2004) Antidiabetic effect of aqueous extrat of Tamarindus indica in STZ-induced diabetic rats. J. Ethnopharmacol. 92, 85-91. https://doi.org/10.1016/j.jep.2004.02.002
  10. Majumdar M, Nayeem N, Kamat JV, Asad Md. (2007) Evaluation of Tectona grandis Leaves for wound healing activity. Pakistan J. Pharma. Sci. 20, 120-124.
  11. Matsudha H, Morikawa T, Yoshikawa M. (2002) Antidiabetogenic constituents from several natural medicine. Pure Appl. Chem. 74, 1301-1308. https://doi.org/10.1351/pac200274071301
  12. Morehouse L, Ban Gerter FW, Ninno M, Inskeep B, Carthy P, Pethini J. (1999) Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: evidence for a non-stoichiometric, intestinal mechanism of action. J. Lipid Res. 40, 464-437.
  13. Murali B, Goyal RK. (2002) Effect of chronic treatment with Losartan on Streptozotocin induced diabetic rats. Indian J. Expt. Biol. 40, 31-34.
  14. OECD (2001) Guidelines for Testing of Chemicals 425, Acute Oral Toxicity-Up-and-Down Procedure, p. 1-26.
  15. Ozturk Y, Altan VM, Ari N. (1998) Diabetic Complications in Experimental Models. Tr. J. Med. Sci. 22, 331-341.
  16. Pandey BL, Goel RK, Pathak NKR, Biswas M, Das PK. (1982) Effect of Tectona grandis Linn. (common Teak tree) on experimental ulcers and gastric secretion.Indian J. Med. Res. 76, 89-94.
  17. Prince PSM, Kamalakkannan N, Menon VP. (2004) Antidiabetic and antihyperlipidaemic effect of alcoholic Syzigium cumini seeds in alloxan induceddiabetic albino rats. J. Ethnopharmacol. 91, 209–213.
  18. Reshmi CR, Fatima A, Sinilal B and Latha MS. (2001) Antidiabetic effect of herbal drug in Alloxan diabetic rats. Indian Drugs 38, 319-322.
  19. Robbins and Cotran. (2004) The endocrine pancreas. Pathologic basis of disease, pp. 1189-1207, Elsevier India.
  20. Schimmer BP, Parker KL. (2001) Adrenocorticotropic Hormone; Adrenocortical Steroids and their Synthetic Analogs; Inhibitors of Synthesis and Actions of Adrenocortical Hormones. In: Hardman JG, Limbard LE, Gilman AG, Goodman-Gilman A, eds., Goodman & Gilman’s The Pharmacological Basis of Therapeutics. p. 1658-1659, McGraw-Hill.
  21. Sumthong P, Damveld RA, Choi YH, Arentshorst M, Ram AFJ, Van den Hondel CAMJJ, Verpoorte R. (2006) Activity of Quinones from Teak (Tectona grandis) on Fungal Cell Wall Stress. Planta Med. 72, 943-944. https://doi.org/10.1055/s-2006-946676
  22. The Ayurvedic Pharmacopoeia of India. (1996) Part I, Vol. IV, pp. 122-123, The Controllers of Publications Civil lines, Delhi.